International Assets Investment Management LLC Acquires 164,557 Shares of Thermo Fisher Scientific Inc. $TMO

International Assets Investment Management LLC lifted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3,023.3% in the third quarter, Holdings Channel reports. The firm owned 170,000 shares of the medical research company’s stock after buying an additional 164,557 shares during the period. Thermo Fisher Scientific comprises about 1.8% of International Assets Investment Management LLC’s portfolio, making the stock its 4th largest position. International Assets Investment Management LLC’s holdings in Thermo Fisher Scientific were worth $114,758,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new stake in Thermo Fisher Scientific in the second quarter valued at about $15,501,867,000. Corient Private Wealth LP purchased a new stake in shares of Thermo Fisher Scientific during the second quarter worth about $382,547,000. Bank of New York Mellon Corp acquired a new position in shares of Thermo Fisher Scientific during the second quarter valued at about $1,974,561,000. Bank of America Corp DE acquired a new position in shares of Thermo Fisher Scientific during the second quarter valued at about $1,952,930,000. Finally, Legal & General Group Plc purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter valued at approximately $1,122,351,000. 89.23% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, VP Lisa Britt sold 11,440 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $613.12, for a total transaction of $7,014,092.80. Following the completion of the transaction, the vice president directly owned 14,784 shares in the company, valued at $9,064,366.08. The trade was a 43.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Marc Casper sold 10,000 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $629.27, for a total transaction of $6,292,700.00. Following the transaction, the chief executive officer owned 123,925 shares of the company’s stock, valued at $77,982,284.75. This represents a 7.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 50,046 shares of company stock valued at $30,779,192 over the last 90 days. Insiders own 0.33% of the company’s stock.

Thermo Fisher Scientific Stock Performance

Shares of Thermo Fisher Scientific stock traded up $17.99 on Friday, reaching $694.93. 2,090,723 shares of the stock were exchanged, compared to its average volume of 2,372,406. The business has a 50 day moving average price of $661.03 and a two-hundred day moving average price of $554.78. The firm has a market capitalization of $257.48 billion, a price-to-earnings ratio of 36.65, a PEG ratio of 2.78 and a beta of 0.84. Thermo Fisher Scientific Inc. has a twelve month low of $435.27 and a twelve month high of $712.17. The company has a quick ratio of 1.41, a current ratio of 1.81 and a debt-to-equity ratio of 0.71.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 21st. The medical research company reported $6.68 earnings per share for the quarter, topping the consensus estimate of $6.40 by $0.28. Thermo Fisher Scientific had a net margin of 14.94% and a return on equity of 17.33%. The company had revenue of $12.14 billion for the quarter, compared to the consensus estimate of $11.95 billion. During the same quarter in the prior year, the company earned $5.79 EPS. Thermo Fisher Scientific’s quarterly revenue was up 9.1% on a year-over-year basis. Analysts anticipate that Thermo Fisher Scientific Inc. will post 25.26 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Tuesday, December 15th will be paid a $0.47 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.3%. Thermo Fisher Scientific’s dividend payout ratio is presently 9.92%.

Wall Street Analyst Weigh In

A number of analysts recently commented on TMO shares. Jefferies Financial Group reiterated a “buy” rating and issued a $630.00 target price (up from $585.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 23rd. Argus upped their price target on shares of Thermo Fisher Scientific from $560.00 to $780.00 and gave the company a “buy” rating in a research note on Friday, October 30th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Thermo Fisher Scientific from $720.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. CLSA assumed coverage on shares of Thermo Fisher Scientific in a research note on Thursday, September 3rd. They set an “outperform” rating and a C$748.00 price objective for the company. Finally, Evercore dropped their price objective on shares of Thermo Fisher Scientific from $720.00 to $615.00 and set an “outperform” rating on the stock in a report on Wednesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Thermo Fisher Scientific presently has an average rating of “Moderate Buy” and a consensus target price of $683.64.

More Thermo Fisher Scientific News

Here are the key news stories impacting Thermo Fisher Scientific this week:

• Positive Sentiment: The board authorized up to $5 billion in share repurchases, replacing the prior authorization, which had $1 billion remaining. The program has no expiration date and could support per-share results and signal confidence in the business. Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
• Positive Sentiment: Recent quarterly results were better than expected: EPS of $6.68 beat the $6.40 consensus, while revenue of $12.14 billion exceeded estimates and increased 9.1% year over year. Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
• Positive Sentiment: Thermo Fisher declared a quarterly dividend of $0.47 per share, payable January 15, 2027. The annualized dividend is $1.88 per share, though the indicated yield is modest at about 0.3%. Thermo Fisher Scientific Announces Quarterly Dividend
• Positive Sentiment: The company introduced value-priced AmpSure qPCR master mixes, adding an offering aimed at labs seeking dependable testing performance at lower cost. Thermo Fisher Introduces AmpSure Universal qPCR Master Mixes
• Neutral Sentiment: Market research reports point to growth in oligonucleotide synthesis, mRNA manufacturing, protein labeling and Q-TOF mass spectrometry—areas related to Thermo Fisher’s markets. These industry forecasts suggest potential demand tailwinds, but do not provide company-specific sales or earnings guidance. Global Oligonucleotide Synthesis Services Market Report 2026

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific develops and supplies products and services used in scientific research, clinical diagnostics, and pharmaceutical and biotechnology manufacturing. Its offerings include laboratory instruments, reagents and consumables, analytical equipment, diagnostic tests, and services that support drug development and clinical research.

The company operates through businesses focused on life sciences, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.